Comparison of the Efficacy of EGFR-TKI Combined with Chemotherapy and Bevacizumab in Advanced EGFR-Mutated Non-small Cell Lung Cancer Patients

JIAO Shuyue; ZHANG Xiao; ZHU Hui; TANG Hong

doi:10.3969/j.issn.1004-437X.2021.35.004

Home>Articles>Comparison of the Efficacy of EGFR-TKI Combined with Chemotherapy and Bevacizumab in Advanced EGFR-Mutated Non-small Cell Lung Cancer Patients

DOI: 10.3969/j.issn.1004-437X.2021.35.004

Comparison of the Efficacy of EGFR-TKI Combined with Chemotherapy and Bevacizumab in Advanced EGFR-Mutated Non-small Cell Lung Cancer Patients

JIAO Shuyue

ZHANG Xiao

ZHU Hui

TANG Hong

Machine-generated Keywords：

Publication Date：2021-12-15

Online Publishing Date：2026-09-12(First online date of this platform, not the publication date of the document)

Pages：5( 6540-6544 )

Henan Medical Research

ISSN：1004-437X

Year, Vol.(Issue)：2021,30(35)